ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 571,74
-0,80%
Dow Jones
40 211,72
0,53%
DAX
18 500,72
-0,53%
Brent Oil
83,15
-1,41%
Bitcoin
63 707,09
-1,76%
Registration Strip Icon for alerts Inscrivez-vous pour des alertes en temps réel, un portefeuille personnalisé et des mouvements de marché.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. Summit Therapeutics Inc (SMMT)

  7. Summit Therapeutics Inc (SMMT) Actualités

SMMT

Summit Therapeutics (SMMT)

Summit Therapeutics Inc
De:
Trier par:
 Showing the most relevant articles for your search:NASDAQ:SMMT
DateHeureSourceTitreSymboleSociété
17/03/202221h14GlobeNewswire Inc.Summit Therapeutics Inc Reports Financial Results and Operational Progress for the Fourth Quarter and Year Ended December 31, 2021NASDAQ:SMMTSummit Therapeutics Inc
11/03/202222h47Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:SMMTSummit Therapeutics Inc
09/02/202214h00GlobeNewswire Inc.Summit Therapeutics Announces Postponement of Its Planned Rights OfferingNASDAQ:SMMTSummit Therapeutics Inc
25/01/202213h30GlobeNewswire Inc.Summit Therapeutics Announces Rights OfferingNASDAQ:SMMTSummit Therapeutics Inc
10/01/202214h00GlobeNewswire Inc.Summit Therapeutics Today Presents Its Company Vision at 40th Annual J.P. Morgan Healthcare Virtual ConferenceNASDAQ:SMMTSummit Therapeutics Inc
05/01/202222h09Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:SMMTSummit Therapeutics Inc
05/01/202213h30GlobeNewswire Inc.Summit Therapeutics to Present Company Vision at 40th Annual J.P. Morgan Healthcare Virtual ConferenceNASDAQ:SMMTSummit Therapeutics Inc
21/12/202112h16TipRanksH.C. Wainwright Remains a Hold on Summit Therapeutics (SMMT)NASDAQ:SMMTSummit Therapeutics Inc
20/12/202114h30GlobeNewswire Inc.Summit Therapeutics Announces Topline Results for Phase III Ri-CoDIFy Study for C. Difficile InfectionNASDAQ:SMMTSummit Therapeutics Inc
15/11/202114h47Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:SMMTSummit Therapeutics Inc
15/11/202114h30GlobeNewswire Inc.Summit Therapeutics Inc Reports Financial Results and Operational Progress for the Third Quarter and Nine Months Ended September 30, 2021NASDAQ:SMMTSummit Therapeutics Inc
03/11/202113h30GlobeNewswire Inc.Summit Therapeutics Bolsters Its Board of Directors with Seasoned Regulatory & Clinical Research Executive Dr. Urte GaykoNASDAQ:SMMTSummit Therapeutics Inc
08/10/202114h30GlobeNewswire Inc.Summit Therapeutics Appoints Prominent Biotech Attorney and Advisor Kenneth A. Clark to Its Board of DirectorsNASDAQ:SMMTSummit Therapeutics Inc
30/09/202115h00GlobeNewswire Inc.Summit Therapeutics Presents Further Breakthrough Insights Surrounding the Novel Mechanism of Action for its Investigational Drug Ridinilazole During IDWeek 2021NASDAQ:SMMTSummit Therapeutics Inc
30/09/202114h00PR Newswire (US)Antimicrobials Working Group Highlights Member Company Participation at IDWeek 2021NASDAQ:SMMTSummit Therapeutics Inc
11/08/202114h01GlobeNewswire Inc.Summit Therapeutics Reports Financial Results and Operational Progress for the Second Quarter and Six Months Ended June 30, 2021NASDAQ:SMMTSummit Therapeutics Inc
11/08/202114h00GlobeNewswire Inc.Summit Therapeutics Provides Update on Ri-CoDIFy TrialsNASDAQ:SMMTSummit Therapeutics Inc
05/08/202114h00PR Newswire (US)Acurx Pharmaceuticals Joins the Antimicrobials Working GroupNASDAQ:SMMTSummit Therapeutics Inc
12/07/202114h29GlobeNewswire Inc.Summit Therapeutics Presents Breakthrough Research Data from Phase II Studies, including Evidence Validating Microbiome Prese...NASDAQ:SMMTSummit Therapeutics Inc
01/07/202114h00GlobeNewswire Inc.Summit Therapeutics to Present Breakthrough Research Updates at the 31st Annual ECCMID Conference, including a Top-Rated ePos...NASDAQ:SMMTSummit Therapeutics Inc
17/06/202117h01Edgar (US Regulatory)Confidential Treatment Order (ct Order)NASDAQ:SMMTSummit Therapeutics Inc
08/06/202117h18PR Newswire (US)Crestone Joins Antimicrobials Working GroupNASDAQ:SMMTSummit Therapeutics Inc
08/06/202113h00GlobeNewswire Inc.Summit Therapeutics set to join Russell 3000® IndexNASDAQ:SMMTSummit Therapeutics Inc
03/06/202114h00GlobeNewswire Inc.Summit Therapeutics’ Upcoming Annual Shareholders’ MeetingNASDAQ:SMMTSummit Therapeutics Inc
18/05/202113h00GlobeNewswire Inc.Summit Therapeutics Announces Preclinical Candidate and Associated CARB-X Funding Support for the Treatment of Infections Cau...NASDAQ:SMMTSummit Therapeutics Inc
17/05/202114h00GlobeNewswire Inc.Summit Therapeutics Reports Financial Results and Operational Progress for the First Quarter Ended March 31, 2021NASDAQ:SMMTSummit Therapeutics Inc
14/05/202122h28Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:SMMTSummit Therapeutics Inc
12/05/202120h58GlobeNewswire Inc.Summit Therapeutics Announces Closing of $75 Million Rights OfferingNASDAQ:SMMTSummit Therapeutics Inc
06/05/202114h00GlobeNewswire Inc.Summit Therapeutics Publishes Scientific Updates to Corporate WebsiteNASDAQ:SMMTSummit Therapeutics Inc
05/05/202118h47GlobeNewswire Inc.Summit Therapeutics’ Rights Offering Nearing Expiration Date; Robert W. Duggan Declares Intention to Fully Oversubscribe in...NASDAQ:SMMTSummit Therapeutics Inc
 Showing the most relevant articles for your search:NASDAQ:SMMT

Dernières Valeurs Consultées

EU
VIV
Vivendi
EU
CAP
Capgemini
EU
PX1
CAC 40
USI
USTECH100
US Tech 100
EU
DG
Vinci
EU
RI
Pernod Ricard
EU
CS
Axa
NASDAQ
MSFT
Microsoft
SPI
SP500
S&P 500
NYSE
MRK
Merck
NYSE
KO
Coca Cola
NASDAQ
AMZN
Amazon.com
NASDAQ
GOOGL
Alphabet
EU
LR
Legrand
EU
EN
Bouygues
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés